人民财讯9月17日电，企查查APP显示，近日，招商局融资租赁(上海)有限公司发生工商变更，杨皓卸任 法定代表人、执行董事、总经理，由张瀚接任法定代表人并担任经理，注册资本由14亿元增至21.5亿 元，同时，多位主要人员任职信息均发生变更。企查查信息显示，该公司成立于2019年7月，经营范围 包含融资租赁业务、第三类医疗设备租赁、第三类医疗器械经营、第二类医疗设备租赁、第二类医疗器 械销售，该公司由招商局融资租赁有限公司全资持股。 ...

| 我自有九州的窗 作者 全国企业信用查询系 | (x) 招商局融资租赁(上海)有限公司 | 查一下 1 一周五十 | | --- | --- | --- | | 基本信息 53 | 法律诉讼 经营风险 16 经营信息 9 | 企业发展 817 知识产 | | 统一社会信用代码 | 91310115MA1K4D9G2R 企业名称 | 招商局融资租赁(上海)有限公司 曾用各 招商局设备租赁 (上海) 有限公司 (2019-07 至 202( | | | 登记状态 | 存续(在营、开业、在册) 成立日期 | | 法定代表人 | 张瀚 【飞关联企业 2 注册资本 | 215000万元 剑 实缴资本 | | 组织机构代码 | MA1K4D9G-2 工商注册号 | 310141000548942 纳税人识别号 | | 企业类型 资) | 有限责任公司(外商投资企业法人独 营业期限 | 2019-07-22 至 无固定期限 纳税人资质 | | 人员规模 | 少于50人 参保人数 | 33 (2024年报) 核准日期 | | 所属地区 | 上海市浦东新区 登记机关 | 自由贸易试验区临港新片区市场监督管理局 | | 国标行 ...

天眼查工商信息显示，近日，招商局融资租赁（上海）有限公司发生工商变更，杨皓卸任法定代表人、 执行董事、总经理，由张瀚接任法定代表人并担任经理，注册资本由14亿人民币增至21.5亿人民币，增 幅约54%，同时，多位主要人员任职信息均发生变更。该公司成立于2019年7月，经营范围为融资租赁 业务、第三类医疗设备租赁、第三类医疗器械经营、第二类医疗设备租赁、第二类医疗器械销售。股东 信息显示，该公司由招商局融资租赁有限公司全资持股。 ...

天眼查App显示，近日，沅陵县烜健医疗器械店（个人独资）成立，法定代表人为张海涛，注册资本5 万人民币，经营范围为一般项目：第二类医疗器械销售。（除依法须经批准的项目外，凭营业执照依法 自主开展经营活动）许可项目：第三类医疗设备租赁；第三类医疗器械经营。（依法须经批准的项目， 经相关部门批准后方可开展经营活动，具体经营项目以相关部门批准文件或许可证件为准）。 ...

Group 1 - The core point of the article is the establishment of a new medical health management company, Tengxiang (Shandong) Medical Health Management Co., Ltd., with a registered capital of 10 million yuan [1] - The company's business scope includes medical services, operation of Class III medical devices, food sales, and leasing of Class III medical equipment [1] - The company is jointly held by Xiangyu Medical (688626) and other stakeholders [1]

General Information - The company is named Shenzhen Huitai Medical Equipment Co., Ltd. and was established through the overall change of Shenzhen Huitai Medical Equipment Co., Ltd. [2] - The company was registered with a capital of RMB 141,013,796 and is a permanent corporation [2][3] - The company was approved for listing on the Shanghai Stock Exchange's Sci-Tech Innovation Board on September 8, 2020, and officially listed on January 7, 2021, with an initial public offering of 16.67 million shares [2] Business Objectives and Scope - The company's business objective is to focus on independent innovation and development in the field of vascular minimally invasive intervention, contributing significantly to global healthcare [2] - The business scope includes the production, operation, and leasing of various classes of medical devices, as well as technology services and development [2] Share Structure - The total number of shares issued by the company is 141,013,796, all of which are ordinary shares [3] - The company’s shares are issued in the form of stocks, and each share of the same category has equal rights [3][4] Shareholder Rights and Responsibilities - Shareholders have the right to participate in shareholder meetings, receive dividends, and request information about the company [5][6] - Shareholders are obligated to comply with laws and regulations, pay for their subscribed shares, and not abuse their rights to harm the company or other shareholders [8][9] Governance Structure - The company is governed by a board of directors, with the chairman serving as the legal representative [2][3] - The company has established an audit committee to oversee compliance and financial integrity [8] Shareholder Meetings - The company holds annual and temporary shareholder meetings, with specific procedures for calling and conducting these meetings [12][13] - Shareholders holding more than 10% of the shares can request the board to convene a temporary meeting [13][14] Financial Management - The company can increase its capital through various methods, including issuing shares to unspecified or specific targets [3][4] - The company is restricted from repurchasing its shares except under certain conditions, such as capital reduction or employee stock ownership plans [3][4] Compliance and Legal Framework - The company adheres to the Company Law and Securities Law of the People's Republic of China, ensuring that all operations are compliant with relevant regulations [2][5] - The company is required to disclose significant transactions and maintain transparency with shareholders [10][11]